• Citing Article List

    The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitors”.
    No. Publication Date Citing Article
    1 2023 Camille A McAloney, Rawan Makkawi, Yogesh Budhathoki, Matthew V Cannon, Emily M Franz, Amy C Gross, Maren Cam, Tatyana A Vetter, Rebekka Duhen, Alexander E Davies, Ryan D Roberts. 2023;   https://doi.org/10.21203/rs.3.rs-3129411/v1
    2 2022 Nicolas Thomas Iannozzi, Valentina Marchica, Denise Toscani, Jessica Burroughs Garcìa, Nicola Giuliani, Paola Storti. Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple Myeloma, International Journal of Molecular Sciences. 2022; 23: 15448.  https://doi.org/10.3390/ijms232415448
    3 2024 Vincenzo Raimondi, Rosanna Vescovini, Mattia Dessena, Gaetano Donofrio, Paola Storti, Nicola Giuliani. Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients, Frontiers in Immunology. 2024; 15: 1483806.  https://doi.org/10.3389/fimmu.2024.1483806
    4 2024 Camille A. McAloney, Rawan Makkawi, Yogesh Budhathoki, Matthew V. Cannon, Emily M. Franz, Amy C. Gross, Maren Cam, Tatyana A. Vetter, Rebekka Duhen, Alexander E. Davies, Ryan D. Roberts. Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization, Cellular Oncology. 2024; 47: 259.  https://doi.org/10.1007/s13402-023-00867-w
    5 2024 Mohamed H. Elbahoty, Bhavyasree Papineni, Rajeev S. Samant. Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics, Clinical & Experimental Metastasis. 2024; 41: 829.  https://doi.org/10.1007/s10585-024-10305-2